Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
7.95
-0.16 (-1.97%)
At close: May 24, 2024, 4:00 PM
8.34
+0.39 (4.91%)
After-hours: May 24, 2024, 7:21 PM EDT

Acrivon Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
21.088.712.471.3
Research & Development
46.0223.9513.721.87
Operating Expenses
67.132.6616.183.17
Operating Income
-67.1-32.66-16.18-3.17
Other Expense / Income
-6.72-1.490.062.14
Pretax Income
-60.39-31.17-16.24-5.31
Net Income
-60.39-31.17-16.24-5.31
Shares Outstanding (Basic)
22421
Shares Outstanding (Diluted)
22421
Shares Change
435.63%136.43%21.70%-
EPS (Basic)
-2.74-7.56-9.32-3.70
EPS (Diluted)
-2.74-7.56-9.32-3.70
Free Cash Flow
-43.93-32.28-14.22-2.82
Free Cash Flow Per Share
-1.99-7.83-8.16-1.97
EBITDA
-59.07-30.07-15.41-5.29
Depreciation & Amortization
1.311.10.830.01
EBIT
-60.39-31.17-16.24-5.31
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).